Key result
PCV2 infection upregulates host reactive oxygen species to expel nuclear HMGB1 into the cytosol, preventing sequestration of its genome and enhancing viral replication.
PCV2 enhances its replication by upregulating host ROS to drive nucleocytoplasmic translocation of HMGB1, suggesting a pharmacological basis for antioxidants as adjunct therapy in PCV2 infection.
Porcine circovirus type 2 (PCV2) is a small DNA virus that depends heavily on host cells for its infection. This study reports the close relationship between subcellular localization of host high-mobility-group box 1 (HMGB1) protein and viral replication during PCV2 infection. Restriction of PCV2 replication by nuclear HMGB1 is the early step of host defense at the host-pathogen interface. PCV2 then upregulates host reactive oxygen species (ROS) to prevent sequestration of its genome by expelling nuclear HMGB1 into the cytosol. It will be interesting to study if a similar evasion strategy is employed by other circoviruses such as beak and feather disease virus, recently discovered PCV3, and geminiviruses in plants. This study also provides insight into the justification and pharmacological basis of antioxidants as an adjunct therapy in PCV2 infection or possibly other diseases caused by the viruses that deploy the ROS-HMGB1 interaction favoring their replication.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2020) studied Porcine circovirus type 2 (PCV2) infection. PCV2 infection was evaluated on Subcellular localization of host HMGB1 protein and viral replication. PCV2 infection upregulates host reactive oxygen species to expel nuclear HMGB1 into the cytosol, preventing sequestration of its genome and enhancing viral replication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: